Laurus Labs Limited — Board/Management Information 2025

Mar 28, 2025

March 28, 2025

==> picture [190 x 81] intentionally omitted <==

To The Corporate Relations Department BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400 001 Code: 540222	To The Listing Department National Stock Exchange of India Ltd., Exchange Plaza, Bandra Kurla Complex, Bandra (E), Mumbai – 400 051 Code: LAURUSLABS

Sub: Intimation of re-appointment of Executive Directors of the Company under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Dear Sir / madam,

Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations"), we wish to inform that, based upon recommendation of the Nomination and Remuneration Committee, the Board of Directors of the Company at its meeting held today i.e., March 28, 2025, has, inter alia, approved:

1. Re-appointment of Dr. Satyanarayana Chava (DIN: 00211921) as an as Executive Director and CEO of the Company.

Dr. Satyanarayana Chava has been re-appointed as an Executive Director and CEO of the Company for a further period of 5 years with effect from April 01, 2025, subject to the approval of the Shareholders of the Company.

2. Re-appointment of Mr. V.V. Ravi Kumar (DIN: 01424180) as an as Executive Director and CFO of the Company.

Mr. V.V. Ravi Kumar has been re-appointed as an Executive Director and CFO of the Company for a further period of 2 years with effect from April 01, 2025, subject to the approval of the Shareholders of the Company.

Further, as per the requirement of the BSE Circular No. List/Comp/14/2018-19 and NSE Circular No. NSE/CML/2018/24 both dated 20[th] June, 2018, on the subject of enforcement of SEBI Orders regarding appointment of Directors by listed companies, we hereby affirm that the Directors being re-appointed are not debarred from holding the office of director by virtue of any order of SEBI or any other such authority.

The required details under SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, are enclosed as Annexure-A .

Please take the above information on record.

Yours faithfully,

For Laurus Labs Limited

VENKATESWA Digitally signed by VENKATESWAR REDDY R REDDY GOGIREDDY GOGIREDDY Date: 2025.03.28 13:36:43 +05'30'

G. Venkateswar Reddy

Company Secretary & Compliance Officer

Encl: A/a

==> picture [453 x 76] intentionally omitted <==

Annexure-A

==> picture [190 x 81] intentionally omitted <==

BRIEF DETAILS OF THE DIRECTORS

(Pursuant to SEBI Master Circular no. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024)

1. Re-appointment of Dr. Satyanarayana Chava (DIN: 00211921) as an as Executive Director and CEO of the Company:

Sr. No.		Particulars	Details
1.		Reason for change viz. ~~appointment,~~ re-appointment, ~~resignation, removal, death or~~ ~~otherwise~~	The current term of five years of Dr. Satyanarayana Chava as Executive Director and CEO will complete on March 31, 2025.
2.		Date of ~~appointment~~/re- appointment~~/cessation~~ (as applicable) & term of ~~appointment/~~re-appointment	Re-appointment of Dr. Satyanarayana Chava as Executive Director and CEO for a period of five years w.e.f. April 01, 2025, subject to the approval of the Shareholders
3.		Brief profile (in case of appointment)	Dr. Satyanarayana Chava is the Founder and Chief Executive Officer of Laurus Labs Limited. He has an extensive academic background, holding both a master’s degree and a Ph.D. in Chemistry from Andhra University. He furthered his education with a post-graduate diploma in Quality Management from the World Quality Council and an Executive M.B.A. from the Indian School of Business. With over 30 years of experience in the pharmaceutical industry and around 20 years of experience in the Company, Dr. Chava has played a crucial role in positioning Laurus Labs as a leader in both domestic and international markets.
4.		Disclosure of relationships between directors (in case of appointment of a director)	Dr. Satyanarayana Chava is the father of Mr. Krishna Chaitanya Chava and Mrs. Soumya Chava, Executive Directors of theCompany.

2. Re-appointment of Mr. V.V. Ravi Kumar (DIN: 01424180) as an Executive Director and CFO of the Company:

Sr. No.		Particulars	Details
1.		Reason for change viz. ~~appointment,~~ re-appointment, ~~resignation, removal, death or~~ ~~otherwise~~	The current term of five years of Mr. V.V. Ravi Kumar as Executive Director and CFO will complete on March 31, 2025.
2.		Date of ~~appointment~~/re- appointment~~/cessation~~ (as applicable) & term of ~~appointment/~~re-appointment	Re-appointment of Mr. V.V. Ravi Kumar as Executive Director and CFO for a period of two years w.e.f. April 01, 2025, subject to the approval of the Shareholders
3.		Brief profile (in case of appointment)	Mr. V. V. Ravi Kumar is the Executive Director and Chief Financial Officer of Laurus Labs Limited, bringing over three decades of rich experience, and especially two decades in Laurus itself, in finance, strategy, and corporate leadership. A qualified Cost Accountant from the Institute of Cost and Works Accountants of India, he plays a pivotal role in steering Laurus Labs toward sustainable growth and excellence.

==> picture [453 x 76] intentionally omitted <==

==> picture [190 x 81] intentionally omitted <==

		As a key leader at Laurus Labs, Mr. Ravi Kumar oversees critical business functions, including Finance, Information Technology, Mergers & Acquisitions and Strategic Alliances, Human Resources etc.
4.	Disclosure of relationships between directors (in case of appointment of a director)	Mr. V.V. Ravi Kumar does not have any inter-se relationship with other directors of the Company.

==> picture [453 x 76] intentionally omitted <==

---